Clinical Trials Directory

Trials / Completed

CompletedNCT03366857

Effect of Supplemental Oxygen on Perioperative BNP Concentration in Cardiac Risk Patients

Effect of Supplemental Oxygen on Perioperative Brain Natriuretic Peptide Concentration in Cardiac Risk Patients - A Prospective Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
260 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The effect of supplemental oxygen on surgical site infections was already investigated in several studies before. Although, oxygen is one of the most used medical therapy in hospitalized patients, the influence on the cardiovascular system is still unknown. Available data indicate beneficial effects of supplemental oxygen on cardiovascular function. Because, no evidence exists concerning the perioperative period, it is our objective to investigate supplemental oxygen in cardiac risk patients undergoing major abdominal surgery. Due to the significant reduction of BNP by inhibiting sympathetic nerve activity we hypothesize that supplemental oxygen have beneficial effects in perioperative BNP release in cardiac risk patients undergoing major abdominal surgery.

Conditions

Interventions

TypeNameDescription
DRUGOxygen 30 %The oxygen concentration will be set at 30%.
DRUGOxygen 80 %The oxygen concentration will be set at 80%.

Timeline

Start date
2017-12-01
Primary completion
2019-12-31
Completion
2020-05-30
First posted
2017-12-08
Last updated
2020-06-11

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03366857. Inclusion in this directory is not an endorsement.